Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Other Non-Current Assets (2021 - 2025)

LifeStance Health (LFST) has disclosed Other Non-Current Assets for 5 consecutive years, with $5.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets fell 29.84% to $5.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.4 million, a 29.84% decrease, with the full-year FY2025 number at $5.4 million, down 29.84% from a year prior.
  • Other Non-Current Assets was $5.4 million for Q4 2025 at LifeStance Health, down from $6.1 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $13.0 million in Q3 2023 to a low of $3.3 million in Q2 2021.
  • A 5-year average of $8.1 million and a median of $7.7 million in 2024 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: surged 236.95% in 2022, then tumbled 43.07% in 2024.
  • LifeStance Health's Other Non-Current Assets stood at $3.4 million in 2021, then surged by 213.08% to $10.8 million in 2022, then grew by 0.93% to $10.9 million in 2023, then fell by 29.11% to $7.7 million in 2024, then dropped by 29.84% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Other Non-Current Assets are $5.4 million (Q4 2025), $6.1 million (Q3 2025), and $6.9 million (Q2 2025).